Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity
Background and aims: Doxorubicin (DOX) causes cognitive impairment (chemobrain) in patients with cancer. While DOX damages the cholinergic system, few studies have focused on the protective effects of cholinergic function on chemobrain. The acetylcholinesterase inhibitor galantamine (GAL) demonstrat...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2023-06-01
|
| סדרה: | Brain Sciences |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2076-3425/13/6/971 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|